fosamprenavir: Clinical Trials

6 trials of fosamprenavir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow fosamprenavir: new trials by email Literature Review of fosamprenavir trials Research Report on fosamprenavir

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen
Dolutegravir, PI, 2 NRTI - HIV-1
Phase 4CompletedHospital Universitari Vall d'Hebron Research Institute442015-06-012017-06-14
MARCH Renal Substudy
arm 1 nucleotide analogue reverse transcriptase inhibitors and boosted protease inhibitors, Arm 2 boosted protease inhibitors and maraviroc, Arm 3 nucleotide analogue reverse transcriptase inhibitors and maraviroc - Proteinuria, HIV
Phase 4CompletedKirby Institute762012-06-012016-01-20
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Fosamprenavir - Chronic HIV Infection, HCV Coinfection
Phase 4CompletedFundacion SEIMC-GESIDA422011-03-012014-05-30
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Lovaza, fosamprenavir/ritonavir - Hypertriglyceridemia, HIV Infection
Phase 4CompletedFelizarta, Franco, M.D.362009-09-012012-04-18
"The Once A Day Protease Inhibitor Regimens"
ritonavir-boosted atazanavir, ritonavir-boosted fosamprenavir - HIV Infections
Phase 4CompletedThe University of Texas Health Science Center, Houston762004-05-012014-01-15
Fosamprenavir Expanded Access
fosamprenavir, TelzirĀ® - Infection, Human Immunodeficiency Virus
Phase 4CompletedViiV Healthcare852003-07-012016-09-12

Conditions studied

HIV Infections (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Coinfection (1)  ·  Hypertriglyceridemia (1)  ·  Infections (1)  ·  Proteinuria (1)

Sponsors

Felizarta, Franco, M.D. (1)  ·  Fundacion SEIMC-GESIDA (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Kirby Institute (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  ViiV Healthcare (1)

Countries

Spain (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  Japan (1)  ·  Mexico (1)  ·  Switzerland (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Franco Felizarta, MD (1)  ·  Juan Gonzalez, MD (1)  ·  Mark Kelly, MD (1)  ·  Roberto C Arduino, MD (1)  ·  Waldo Belloso, MD (1)